IBDEI1VP ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,30009,1,4,0)
;;=4^G21.11
;;^UTILITY(U,$J,358.3,30009,2)
;;=^5003772
;;^UTILITY(U,$J,358.3,30010,0)
;;=G24.01^^120^1525^15
;;^UTILITY(U,$J,358.3,30010,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30010,1,3,0)
;;=3^Tardive Dyskinesia
;;^UTILITY(U,$J,358.3,30010,1,4,0)
;;=4^G24.01
;;^UTILITY(U,$J,358.3,30010,2)
;;=^5003784
;;^UTILITY(U,$J,358.3,30011,0)
;;=G24.09^^120^1525^16
;;^UTILITY(U,$J,358.3,30011,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30011,1,3,0)
;;=3^Tardive Dystonia
;;^UTILITY(U,$J,358.3,30011,1,4,0)
;;=4^G24.09
;;^UTILITY(U,$J,358.3,30011,2)
;;=^5003786
;;^UTILITY(U,$J,358.3,30012,0)
;;=G25.1^^120^1525^11
;;^UTILITY(U,$J,358.3,30012,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30012,1,3,0)
;;=3^Medication-Induced Postural Tremor
;;^UTILITY(U,$J,358.3,30012,1,4,0)
;;=4^G25.1
;;^UTILITY(U,$J,358.3,30012,2)
;;=^5003792
;;^UTILITY(U,$J,358.3,30013,0)
;;=G25.71^^120^1525^14
;;^UTILITY(U,$J,358.3,30013,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30013,1,3,0)
;;=3^Tardive Akathisia
;;^UTILITY(U,$J,358.3,30013,1,4,0)
;;=4^G25.71
;;^UTILITY(U,$J,358.3,30013,2)
;;=^5003799
;;^UTILITY(U,$J,358.3,30014,0)
;;=G25.79^^120^1525^9
;;^UTILITY(U,$J,358.3,30014,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30014,1,3,0)
;;=3^Medication-Induced Movement Disorder,Other
;;^UTILITY(U,$J,358.3,30014,1,4,0)
;;=4^G25.79
;;^UTILITY(U,$J,358.3,30014,2)
;;=^5003800
;;^UTILITY(U,$J,358.3,30015,0)
;;=T43.205A^^120^1525^4
;;^UTILITY(U,$J,358.3,30015,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30015,1,3,0)
;;=3^Antidepressant Discontinuation Syndrome,Init Encntr
;;^UTILITY(U,$J,358.3,30015,1,4,0)
;;=4^T43.205A
;;^UTILITY(U,$J,358.3,30015,2)
;;=^5050540
;;^UTILITY(U,$J,358.3,30016,0)
;;=T43.205D^^120^1525^5
;;^UTILITY(U,$J,358.3,30016,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30016,1,3,0)
;;=3^Antidepressant Discontinuation Syndrome,Subseq Encntr
;;^UTILITY(U,$J,358.3,30016,1,4,0)
;;=4^T43.205D
;;^UTILITY(U,$J,358.3,30016,2)
;;=^5050541
;;^UTILITY(U,$J,358.3,30017,0)
;;=T43.205S^^120^1525^6
;;^UTILITY(U,$J,358.3,30017,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30017,1,3,0)
;;=3^Antidepressant Discontinuation Syndrome,Sequela
;;^UTILITY(U,$J,358.3,30017,1,4,0)
;;=4^T43.205S
;;^UTILITY(U,$J,358.3,30017,2)
;;=^5050542
;;^UTILITY(U,$J,358.3,30018,0)
;;=G25.71^^120^1525^7
;;^UTILITY(U,$J,358.3,30018,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30018,1,3,0)
;;=3^Medication-Induced Acute Akathisia
;;^UTILITY(U,$J,358.3,30018,1,4,0)
;;=4^G25.71
;;^UTILITY(U,$J,358.3,30018,2)
;;=^5003799
;;^UTILITY(U,$J,358.3,30019,0)
;;=G24.02^^120^1525^8
;;^UTILITY(U,$J,358.3,30019,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30019,1,3,0)
;;=3^Medication-Induced Acute Dystonia
;;^UTILITY(U,$J,358.3,30019,1,4,0)
;;=4^G24.02
;;^UTILITY(U,$J,358.3,30019,2)
;;=^5003785
;;^UTILITY(U,$J,358.3,30020,0)
;;=G21.0^^120^1525^12
;;^UTILITY(U,$J,358.3,30020,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30020,1,3,0)
;;=3^Neuroleptic Malignant Syndrome
;;^UTILITY(U,$J,358.3,30020,1,4,0)
;;=4^G21.0
;;^UTILITY(U,$J,358.3,30020,2)
;;=^5003771
;;^UTILITY(U,$J,358.3,30021,0)
;;=T50.905A^^120^1525^1
;;^UTILITY(U,$J,358.3,30021,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30021,1,3,0)
;;=3^Adverse Effect of Medication,Other,Init Encntr
;;^UTILITY(U,$J,358.3,30021,1,4,0)
;;=4^T50.905A
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1VP 3793 printed Nov 22, 2024@17:26:54 Page 2
IBDEI1VP ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,30009,1,4,0)
+2 ;;=4^G21.11
+3 ;;^UTILITY(U,$J,358.3,30009,2)
+4 ;;=^5003772
+5 ;;^UTILITY(U,$J,358.3,30010,0)
+6 ;;=G24.01^^120^1525^15
+7 ;;^UTILITY(U,$J,358.3,30010,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,30010,1,3,0)
+10 ;;=3^Tardive Dyskinesia
+11 ;;^UTILITY(U,$J,358.3,30010,1,4,0)
+12 ;;=4^G24.01
+13 ;;^UTILITY(U,$J,358.3,30010,2)
+14 ;;=^5003784
+15 ;;^UTILITY(U,$J,358.3,30011,0)
+16 ;;=G24.09^^120^1525^16
+17 ;;^UTILITY(U,$J,358.3,30011,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,30011,1,3,0)
+20 ;;=3^Tardive Dystonia
+21 ;;^UTILITY(U,$J,358.3,30011,1,4,0)
+22 ;;=4^G24.09
+23 ;;^UTILITY(U,$J,358.3,30011,2)
+24 ;;=^5003786
+25 ;;^UTILITY(U,$J,358.3,30012,0)
+26 ;;=G25.1^^120^1525^11
+27 ;;^UTILITY(U,$J,358.3,30012,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,30012,1,3,0)
+30 ;;=3^Medication-Induced Postural Tremor
+31 ;;^UTILITY(U,$J,358.3,30012,1,4,0)
+32 ;;=4^G25.1
+33 ;;^UTILITY(U,$J,358.3,30012,2)
+34 ;;=^5003792
+35 ;;^UTILITY(U,$J,358.3,30013,0)
+36 ;;=G25.71^^120^1525^14
+37 ;;^UTILITY(U,$J,358.3,30013,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,30013,1,3,0)
+40 ;;=3^Tardive Akathisia
+41 ;;^UTILITY(U,$J,358.3,30013,1,4,0)
+42 ;;=4^G25.71
+43 ;;^UTILITY(U,$J,358.3,30013,2)
+44 ;;=^5003799
+45 ;;^UTILITY(U,$J,358.3,30014,0)
+46 ;;=G25.79^^120^1525^9
+47 ;;^UTILITY(U,$J,358.3,30014,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,30014,1,3,0)
+50 ;;=3^Medication-Induced Movement Disorder,Other
+51 ;;^UTILITY(U,$J,358.3,30014,1,4,0)
+52 ;;=4^G25.79
+53 ;;^UTILITY(U,$J,358.3,30014,2)
+54 ;;=^5003800
+55 ;;^UTILITY(U,$J,358.3,30015,0)
+56 ;;=T43.205A^^120^1525^4
+57 ;;^UTILITY(U,$J,358.3,30015,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,30015,1,3,0)
+60 ;;=3^Antidepressant Discontinuation Syndrome,Init Encntr
+61 ;;^UTILITY(U,$J,358.3,30015,1,4,0)
+62 ;;=4^T43.205A
+63 ;;^UTILITY(U,$J,358.3,30015,2)
+64 ;;=^5050540
+65 ;;^UTILITY(U,$J,358.3,30016,0)
+66 ;;=T43.205D^^120^1525^5
+67 ;;^UTILITY(U,$J,358.3,30016,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,30016,1,3,0)
+70 ;;=3^Antidepressant Discontinuation Syndrome,Subseq Encntr
+71 ;;^UTILITY(U,$J,358.3,30016,1,4,0)
+72 ;;=4^T43.205D
+73 ;;^UTILITY(U,$J,358.3,30016,2)
+74 ;;=^5050541
+75 ;;^UTILITY(U,$J,358.3,30017,0)
+76 ;;=T43.205S^^120^1525^6
+77 ;;^UTILITY(U,$J,358.3,30017,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,30017,1,3,0)
+80 ;;=3^Antidepressant Discontinuation Syndrome,Sequela
+81 ;;^UTILITY(U,$J,358.3,30017,1,4,0)
+82 ;;=4^T43.205S
+83 ;;^UTILITY(U,$J,358.3,30017,2)
+84 ;;=^5050542
+85 ;;^UTILITY(U,$J,358.3,30018,0)
+86 ;;=G25.71^^120^1525^7
+87 ;;^UTILITY(U,$J,358.3,30018,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,30018,1,3,0)
+90 ;;=3^Medication-Induced Acute Akathisia
+91 ;;^UTILITY(U,$J,358.3,30018,1,4,0)
+92 ;;=4^G25.71
+93 ;;^UTILITY(U,$J,358.3,30018,2)
+94 ;;=^5003799
+95 ;;^UTILITY(U,$J,358.3,30019,0)
+96 ;;=G24.02^^120^1525^8
+97 ;;^UTILITY(U,$J,358.3,30019,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,30019,1,3,0)
+100 ;;=3^Medication-Induced Acute Dystonia
+101 ;;^UTILITY(U,$J,358.3,30019,1,4,0)
+102 ;;=4^G24.02
+103 ;;^UTILITY(U,$J,358.3,30019,2)
+104 ;;=^5003785
+105 ;;^UTILITY(U,$J,358.3,30020,0)
+106 ;;=G21.0^^120^1525^12
+107 ;;^UTILITY(U,$J,358.3,30020,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,30020,1,3,0)
+110 ;;=3^Neuroleptic Malignant Syndrome
+111 ;;^UTILITY(U,$J,358.3,30020,1,4,0)
+112 ;;=4^G21.0
+113 ;;^UTILITY(U,$J,358.3,30020,2)
+114 ;;=^5003771
+115 ;;^UTILITY(U,$J,358.3,30021,0)
+116 ;;=T50.905A^^120^1525^1
+117 ;;^UTILITY(U,$J,358.3,30021,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,30021,1,3,0)
+120 ;;=3^Adverse Effect of Medication,Other,Init Encntr
+121 ;;^UTILITY(U,$J,358.3,30021,1,4,0)
+122 ;;=4^T50.905A
